Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Expert Review of Precision Medicine and Drug Development|July 10, 2019
Use of big data in drug development for precision medicine: an updateTongqi Qian, Shijia Zhu, Yujin Hoshida
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 24, 2020
Omics-derived hepatocellular carcinoma risk biomarkers for precision care of chronic liver diseasesNaoto Fujiwara, Tongqi Qian, Bhuvaneswari Koneru, et al.
Bioinformatics (Oxford, England)|July 17, 2018
GIGSEA: genotype imputed gene set enrichment analysis using GWAS summary level dataShijia Zhu, Tongqi Qian, Yujin Hoshida, et al.
Scientific Reports|February 14, 2020
Restricted immunological and cellular pathways are shared by murine models of chronic alcohol consumptionAlyx Vogle, Tongqi Qian, Shijia Zhu, et al.
Hepatology Communications|June 17, 2022
Atorvastatin favorably modulates a clinical hepatocellular carcinoma risk gene signatureMyung-Ho Kim, Mi-Young Kim, Shadi Salloum, et al.
Cellular and Molecular Gastroenterology and Hepatology|January 30, 2022
Peroxidasin Deficiency Re-programs Macrophages Toward Pro-fibrolysis Function and Promotes Collagen Resolution in LiverMozhdeh Sojoodi, Derek J Erstad, Stephen C Barrett, et al.
Med (New York, N.Y.)|July 28, 2021
A blood-based prognostic liver secretome signature and long-term hepatocellular carcinoma risk in advanced liver fibrosisNaoto Fujiwara, Masahiro Kobayashi, Austin J Fobar, et al.
Science Translational Medicine|June 22, 2022
Molecular signatures of long-term hepatocellular carcinoma risk in nonalcoholic fatty liver diseaseNaoto Fujiwara, Naoto Kubota, Emilie Crouchet, et al.
Pageof 2